Image: Mail OnlineNew mRNA flu shot set to roll out - adults over 50 urged to get shot which uses same tech as controversial Covid vaccine
• Health officials have approved mFLUSIVA, the first mRNA-based flu vaccine developed by Moderna, which is expected to be available by the next flu season. • Clinical data indicates the shot may be 27% more effective than traditional vaccines, though side effects like fatigue and headaches occurred in up to two-thirds of patients. • The rollout follows a severe winter flu season characterized by a virulent strain that led to record-high case numbers across multiple US states.
dailymail.com